2020 JAPAN ENDOVASCULAR CONFERENCE (JET) - Osaka, JAPAN
“The demise of the Bioresorbable Vascular Scaffold: why does it fail?“
“Presentation on the latest VENVO clinical trial data + case experiences”
2020 LEIPZIG INTERVENTIONAL CONGRESS (LINC) - Leipzig, GERMANY
“Long term results and glimpse into the future with bioresorbable scaffold for BTK”
“Trans-radial artery access for lower limb interventions: Will dedicated new tools make this approach the future standard of care?”
“Workflow and ergonomics improvements in the hybrid OR”
“5-year results from the ABSORB BTK study: Bioresorbable scaffolds for the treatment of tibial artery stenosis”
“The role of stents and scaffolds in BTK vessels”
2020 CACVS - Paris, FRANCE
“Is there a future for the bioabsorbable stents: the truth!”
2019 SVESS - Singapore
“DES for BTK”
2019 VIVA - Las Vegas, USA
“Lessons Learned in Severe PAD – Application in Severe Venous Disease”
“What Is the Right Postsurgical Bypass Medical Regimen?”
“My Most Challenging Calcified Tibial Case”
“5 year ABSORB BTK Trial Results”
“Strategies on the Frontline – Alternative Lower Extremity Access to Complete a Difficult Case: Pedal, Tibial, Popliteal, SFA (Case Presentation)”
“Options for Reconstruction in the CLI Patient With TASCD +++ Femoropopliteal Disease”
“What’s the Reason for the Paclitaxel Safety Signal – Trial Design Issues of Newly Identified Biological Mechanism?”
2019 VSICON - Hyderabad, INDIA
“Current treatment strategies for the SFA/Popliteal and Vascular Mimetic Implant (VMI) Clinical Data”
“Endovascular Management of SFA/Popliteal disease”
“Popliteal disease: endovascular is better”
2019 AMP SYMPOSIUM - Chicago, USA
“Paclitaxel: Navigating societies’ and regulatory responses while providing optimal patient care”
“ABSORB Trial Update”
“Overview of Endovascular Devices Available OUS That Can Add Value to US Patients”
“History of Surgical CLI Bypass. Does the Data Meet the Current State of Global CLI? Why?”
“Is Paclitaxel Guilty by Association? What We Know About Its Safety Profile”
2019 CARDIOVASCULAR INNOVATIONS - Denver, USA
“Wire Choice and Approaches to Cross SFA and Popliteal CTOs”
2019 THOUGHT LEADERS FORUM - Hong Kong, CHINA
“Presentation: Intravascular Imaging in Endovascular”
“Bioresorbable Technology - The Ultimate Leave Nothing Behind Strategy?”
2019 VAATDAGEN - Noordwijkerhout, THE NETHERLANDS
“Does Operator Volume make a Difference to Outcomes after Elective and Emergency Aortic Surgery: Results from the Australasian Vascular Audit”
“Management of SFA Disease - My Algorithm, Promise and Limitations of DCB in Long Lesions: Current Insights”
2019 VIVA VASCULAR LEADERS FORUM - Washington DC, USA
“Unintended Consequences of Various Trial Designs and Potential Effect on Mortality and Other Outcomes”
2019 JAPAN ENDOVASCULAR TREATMENT CONFERENCE (JET) - Osaka, JAPAN
“Treatment Strategies for Femoro-Popliteal Calcification”
“Interventional Reconstruction of the Popliteal Artery - How to Approach and How to Stabilise?”
2019 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Leipzig, GERMANY
“The Demise of the Absorb BVS. Why it Failed, What we Learned from the Coronary Experience, and Is There a Future for Bioresorbable Scaffolds Below-The-Knee?”
“Endovenous Valve Formation (EVF) - An Initial Report on the Human Clinical Trial of the First Non-Implantable, Endovenous Approach to Deep Vein Reflux”
2018 VEITH SYMPOSIUM - New York, USA
“Status of Bioresorbable DESs For Treating BTK Arteries: Though they Failed in the Coronary Arteries they Show Promise in the Leg: The ABSORB BTK Trial 4-year Results Show Why”
“Why Endovascular Treatments for CLTI Are More Cost Effective Than Open Surgery Or Amputation in The Drug Eluting Era”
2018 VIVA: VASCULAR INTERVENTIONAL ADVANCES – Las Vegas, USA
“Time to Change the Nomenclature: Rationale”
“Avoiding Acute Arterial Thrombosis, and What To Do When It Happens”
2018 TCT - San Diego, USA
“BlueLeaf: Initial Experience with a Percutaneous Approach to Deep Vein Reflux”
“Dedicated Scaffolds and Stents”
“Intravascular Lithotripsy for Treatment of Calcified Tibial Vessels”
2018 AMP SYMPOSIUM - Chicago, USA
“Infrapopliteal Implants: DES and Beyond”
“Case-Based from Australia: Predictors of Adverse Clinical Outcomes After Infrapopliteal Intervention”
2018 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Asia Pacific, Hong Kong, CHINA
"Promise and Limitations of DCB in Long Lesions: What Have We Learned from Clinical Trials?"
"Endovascular vs. Surgical Carotid Revascularization: Lessons Learned from Clinical Trials and How I Approach it from My Practice"
2018 APSCVIR - Auckland, NEW ZEALAND
"An Analysis of the Contemporary Data Comparing CAS with CEA"
"Endovascular First Approach to All CLI Patients is Cost Effective and Results in Better Limb Salvage"
"The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency: A Prospective, Multi-Centre Case Study"
"First Australian experience with Venaseal (Cyanoacrylate Glue Ablation) for Saphenous Vein Reflux"
"Not all drug eluting stents are as Effective in BTK Arteries: Results from an Updated Systematic Review and Meta-Analysis of RCTs"
"Infrapopliteal Stenting: Bare-Metal, Bioresorbable and DES"
"Choosing the right venous stent for your patient"
2018 JAPAN ENDOVASCULAR TREATMENT CONFERENCE (JET) - Osaka, JAPAN
"Summary of Drug Technology for SFA Disease"
"How To Cross AI-CTO By Australian Style"
"Stenting in Below The Knee Arteries: Update On DES, Bioabsorbable Scaffolds and Future Self-Expanding DES"
"BK-stent Experience: Final Solution"
2018 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Leipzig, GERMANY
“36-Month Results from the ABSORB-BTK Study”
"Matching the Right Venous Stent to your Patient and their Individual Anatomy"
2017 VERVE SYMPOSIUM - Sydney, AUS
“36-Month Results from the ABSORB-BTK Study”
“Individualising Your Patient’s Anatomy to the Attributes of Dedicated Venous Stents”
2017 VEITH SYMPOSIUM - New York, USA
“Combination Therapy for the SFA: The Evidence For Stent And DCB Choice In This Exciting New Space”
“All Drug Eluting Stents Are Not the Same for The Treatment of Infrapopliteal Arteries: Results from An Updated Meta-Analysis Of RCTs”
“Highlights from The Australian VERVE Symposium December 2016: EVAR at 25 Years: Where Is It Going”
“Update On 3-Year Experience with The Absorb Everolimus Drug Eluting Bioresorbable Stent (BRS) From Abbott For BTK Lesions: Promising Results Beyond 2 Years and Future Prospects”
2017 HENDOLAT - Mexico City, MEX
“Infrapopliteal Stenting: Bare Metal, Bioabsorbable and DES"
“The art of angioplasty: how drug ball studies have taught us new things”
“Endovascular venous arterialization: A new option or a nonsense memory?”
“Results of the ABSORB BTK study: bioabsorbable stents in tibial lesions”
2017 AMP SYMPOSIUM - Chicago, USA
“Infrapopliteal Stenting: Bare Metal, Bioabsorbable and DES"
“Late breaking trial: ABSORB BTK: 24 Month Outcomes”
2017 CENTRE FOR CANCER BIOLOGY - Adelaide
“The Conundrum of Restenosis After Contemporary Endovascular Revascularisation for Peripheral Artery Disease: Methods of Prevention and Unmet Needs”
2017 CHARING CROSS SYMPOSIUM – London, UK
“Cost analysis on CLI patients: Impact and benefits on endovascular vs surgical approach”
“Patient choice in deploying a deep venous stent”
“ABSORB study of a bioresorbable drug-eluting scaffold”
“The future of the bioresorbable scaffold for drug elution”
2017 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Asia Pacific, Hong Kong, CHINA
“Promise and limitations of DCB in long lesions: Current insights”
“Carotid artery stenting- Dusk or dawn?”
“2-year results with Absorb BTK – Australia experience”
“Effect of technique on SUPERA results”
2017 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Leipzig, GERMANY
“Bioresorbable Scaffolds in BTK Arteries: 24-month results from the ABSORB BTK Study”
“A Cost-Analysis Study Comparing Endovascular and Surgical Options for Patients with Chronic Lower Limb Ischaemia”
“The Use of Adjunctive Venography and Endovascular Maneuvers In The Treatment of Saphenous Vein Insufficiency: A Prospective, Multi-Centre Study”
2016 VEITH SYMPOSIUM – New York, USA
“Favourable 1-2 Year Results with The Abbott Balloon Expandable Bioresorbable Drug Eluting Stent For BTK Occlusive Lesions. Do the Lesions Regress: The ABSORB BTK Trial”
2016 ASIAN SOCIETY OF VASCULAR SURGERY – Singapore
“A new Generation DES for the SFA – 2 year results of the Eluvia Stent”
“The Use of Bioresorbable Vascular Scaffolds in the Treatment of Arterial Disease of the Lower Limb”
“Management of SFA Disease – My Algorithm”
MASSACHUSETTS GENERAL HOSPITAL & HARVARD MEDICAL SCHOOL – Boston, USA
“The Treatment of Carotid Stenosis in 2016: Working Towards a Patient Specific Algorithm”
“Peripheral Artery Disease from the Aorta to the Feet: Best Practice and Advanced Endovascular Techniques”
“The Visionary Pioneers of Vascular Surgery: From Antiquity to Present Day”
2016 VIVA: VASCULAR INTERVENTIONAL ADVANCES – Las Vegas, USA
“Bioabsorbable Scaffolds – Experience From Absorb BVS and Other Insights as to Whether this will be Enduring Therapy for CLI”
“Aorto-iliac Duplex Results: Implications for Additional Diagnostic Imaging, Procedural Access and Interventional Planning”
“Femoropopliteal Disease: Hybrid Approach”
“How and Why to Develop a Primarily Percutaneous AAA Endograft Program”
2016 ANZSVS VASCULAR – Sydney, AUSTRALIA
“The First-in-Man use of a Bioresorbable, Everolimus-Eluting Vascular Scaffold Below-the-Knee”
“First Australian experience with Cyanoacrylate Glue Ablation for Saphenous Vein Reflux”
“The Utility of Adjunctive Digital Subtraction Venography for the Treatment of Saphenous Vein Insufficiency”
2016 AUSTRALASIAN COLLEGE OF PHLEBOLOGY ASC – Ayers Rock, AUSTRALIA
“A Large, Single-Centre Experience with Cyanoacrylate Adhesive Glue Embolisation for Saphenous Vein Insufficiency”
“Interventional Techniques for Severe Pulmonary Embolism”
“Use of Ionising Radiation During Endovenous Ablation”
2016 CHARING CROSS SYMPOSIUM – London, UK
“First experience with a bioresorbable, Everolimus-eluting vascular scaffold in arteries below-the-knee”
“What is eventually going to be successful to make below-the-knee results more durable: drug eluting STENTS, drug coated balloons or bioabsorbable vascular scaffolds?”
“Bioresorbable stents for below-the-knee use”
2016 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Asia Pacific, Hong Kong, CHINA
“Australian experience for complex disease in the femoral and popliteal artery”
“Deep dive: IN.PACT SFA 2-year outcomes”
“12 months results with Absorb BTK”
2016 SINGAPORE CONGRESS OF RADIOLOGY – SINGAPORE
“SFA Disease: POBA, DEB or Stent? When and Where?”
2016 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Leipzig, GERMANY
“Bioabsorbable drug-eluting scaffolds in BTK arteries: Update on the ABSORB BTK project”
“How to optimize outcomes of CLI procedures: What does the future hold?”
2015 VERVE SYMPOSIUM – Sydney, AUSTRALIA
“First Experience With an Everolimus-Eluting, Bioresorbable Scaffold Below-The-Knee: 12-month Clinical and Imaging Outcomes”
2015 VEITH SYMPOSIUM – New York, USA
“1-Year Experience with Drug Eluting (Everolimus) Bioresorbable Stents In BTK Arteries, Including The Tibials”
“An Endovascular First Approach to All CLI Patients Results In Better Limb Salvage: Based on Long-Term Follow-Up of A Single Vascular Surgical Center”
2015 AMP THE CLI MEETING – Chicago, USA
“Wires and Catheters for Aortoiliac and SFA Interventions: 0.014” vs. 0.018”
“Hybrid Revascularization of Aortoiliac and SFA/Popliteal Arteries in CLI”
“Surgical CFA Profunda Reconstruction and Tibial Bypass”
2015 EURO PCR – Paris, FRANCE
“First Experience with an Everolimus-Eluting, Bioresorbable Scaffold Below-The-Knee: 6-month Clinical and Imaging Outcomes”
2015 RECONTRES VASCULAIRES DU VAL D’OR – Paris, FRANCE
“Endovascular vs Open Bypass for Occlusive Disease BTK”
“First Experience with an Everolimus-Eluting, Bioresorbable Scaffold Below-The-Knee: 12-month Clinical and Imaging Outcomes”
2015 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – ASIA PACIFIC, Hong Kong, CHINA
“Initial Experience with Bioabsorbable Scaffolds in BTK Interventions”
“May Thurner syndrome: An emerging but still underdiagnosed condition: How I find it and how I treat it”
“Patient selection for carotid stenting: lessons learned from randomized clinical trials”
“Stenting in BTK and popliteal arteries: Review of the evidence”
“Optimal implantation deployment for optimal clinical outcome with SUPERA”
“Optimal techniques for reconstruction of the aorto-iliac bifurcation – Covered stents are the best solution”
2015 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Leipzig, GERMANY
“A real world experience using SUPERA in long challenging lesions: patency results, deployment pitfalls and insights into mode of failure”
“Initial experience with absorbable drug-eluting vascular scaffolds in BTK arteries”
2014 VERVE SYMPOSIUM – Sydney, AUSTRALIA
“First Experience with the Bioresorbable Vascular Scaffold Below the Knee”
2014 VIVA: VASCULAR INTERVENTIONAL ADVANCES – Las Vegas, USA
“Chemical Versus Mechanical Lysis Versus Surgical Thrombectomy”
“Bare-Metal, Drug-Eluting, Bioabsorbable Stents and Tacks”
2014 ANZSVS VASCULAR 2014 – Canberra, AUSTRALIA
“First Experience with the Below the Knee Bio-resorbable Vascular Scaffold (BVS)”
“Indication for Mechanical Coil Embolisation”
2014 AUSTRALIAN ASSOCIATION OF OBSTETRICAL AND GYNAECOLOGICAL ULTRASONOLOGISTS – Brisbane, AUSTRALIA
“Pelvic Congestion Syndrome: An Under-Recognised Cause for Chronic Pelvic Pain in Women”
2014 RECONTRES VASCULAIRES DU VAL D’OR – Paris, FRANCE
“Management of Complex Aneurysms in Sydney”
2014 SITE – Barcelona, SPAIN
2014 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – ASIA PACIFIC, Hong Kong, CHINA
“Initial Experience with Bioabsorbable Scaffolds in BTK Interventions”
“The Role of Vessel Preparation to Optimize Outcomes”
“Indications for Mechanical Coil Embolisations”
“Patient Specific Decisions in Carotid Revascularisation – How I Do it”
“Parallel Graft Techniques Including Chimneys and Snorkels – A Real Alternative?”
2014 VASCULAR SOCIETY OF NEW ZEALAND – Wellington, NZ
“Retrograde Puncture and Advanced Endovascular Revascularisation: My Toolbox”
2014 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Leipzig, GERMANY
“Reconstruction of Complex Aortoiliac Lesions – Covered vs Uncovered Stents”
“How I Make my Treatment Decisions – Insights from a Surgical High-Volume CAS Center”
“How Far Can We Go with Endovascular Techniques in Challenging CTOs – The Viewpoint of a Surgeon”
2013 VERVE SYMPOSIUM – Sydney, AUSTRALIA
“First Experience with the Bioresorbable Vascular Scaffold Below the Knee”
“Optimal Techniques for Reconstruction of the Aortic Bifurcation”
2013 RACS ANNUAL SCIENTIFIC CONGRESS, Auckland, NEW ZEALAND
“With All These Endovascular Tools How Do I Know When to Operate” – KEYNOTE LECTURE
“Drug Eluting Stents Below the Knee: The Evidence and the Challenges to Their Use in Real World Lesions”
“Advanced Techniques for Conquering Peripheral CTOs”
2013 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – ASIA PACIFIC, Hong Kong, CHINA
“Aortic Dissection: New Frontiers and Latest Data”
“CEA vs. CAS: Cutting Through the Noise of all the Data”
2013 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – Leipzig, GERMANY
“Drug Eluting Stents Below The Knee: the Durable Solution”
“Optimal Techniques for Reconstruction of the Aortic Bifurcation”
2012 VIVA: VASCULAR INTERVENTIONAL ADVANCES, Las Vegas, USA
“Strategies on the Frontline: Thoracic Aorta”
“Strategies on the Frontline: Abdominal Aorta”
2012 ANZSVS VASCULAR 2012, Melbourne, Australia
“The Pathophysiology of Restenosis”
“Strategies for Overcoming the Chronic Total Occlusion”
2012 THE AUSTRALASIAN COLLEGE OF PHLEBOLOGY 15th ANNUAL SCIENTIFIC MEETING, Cairns, QLD
“Percutaneous Venous Angioplasty in Patients with Multiple Sclerosis: An Australian Pilot Study”
2012 AORTIC ASIA SUMMIT, Denpasar, INDONESIA
“Large Vessel Closure: Percutaneous Endovascular Aortic Repair”
2012 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – ASIA PACIFIC, Hong Kong, CHINA
“The Angiosome Concept – How to Choose the Right Artery to Treat”
“How I treat Rutherford Class 4: Theory and Case Review”
“When and How Should the Critical Limb Ischemia Patient Undergo Revascularization?”
“CEA vs. CAS: insights from the CREST trial and latest European data”
2011 VEITH SYMPOSIUM, New York, USA
“CAS Under Ultrasound Guidance Is A Safer, Better Way”
“Intraoperative Ultrasound To Detect Endoleaks Before Sheath Removal To Facilitate Treatment”
2011 INTERNATIONAL CONGRESS FOR ENDOVASCULAR SPECIALISTS, Phoenix, USA
“Endovascular Recanalisation of the Occluded Aorto-Iliac Segment”
2011 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – ASIA PACIFIC, Hong Kong, CHINA
“Techniques for Complex Iliac CTOs and Aortic Occlusions”
“Large Hole Vessel Closure – Latest Update”
“Strategies for Lowering Complications during Thoracic Stent-graft Procedures”
2010 ANZSVS VASCULAR 2010, Gold Coast, QLD
“Endovascular Recanalisation of the Occluded Aorto-Iliac Segment”
2010 VEITH SYMPOSIUM, New York, USA
“Endovascular Recanalization of the Occluded Aorta by a Foolproof Method Using a Reentry Device and Stents to Save Collaterals: Midterm Follow-Up Is Good”
2010 INTERNATIONAL CONGRESS OF CARDIOLOGY, Hong Kong, CHINA
“Endovascular Aortic Repair: A Look into the Future”
“How to Maximize Success and Minimize Complications after Carotid Stenting”
2010 LEIPZIG INTERVENTIONAL CONGRESS (LINC) – ASIA PACIFIC, Hong Kong, CHINA
“Interventional vs Surgical Carotid Revascularisation – How to Select Patients Appropriately”
2009 SURGICAL RESEARCH SOCIETY, Adelaide, SA
“Vascular Anastomosis Using the Nitinol U-Clip Device: An Ovine Arteriovenous Fistula Model”
2009 ANZSVS VASCULAR 2009, Sydney, NSW
“Vascular Anastomosis Using the Nitinol U-Clip Device: An Ovine Arteriovenous Fistula Model”
2008 RACS ANNUAL SCIENTIFIC CONGRESS, Hong Kong, CHINA
“The Prevalence of Carotid Stent Fractures”
2006 ANZSVS VASCULAR 2006, Cairns, QLD
“Arm Vein Bypass Grafts As A Last Autogenous Option For Infrainguinal Bypass Surgery: Are They Worth The Effort?”
2006 NSW REGISTRARS PAPER DAY, Sydney, NSW
“Arm Vein Bypass Grafts As A Last Autogenous Option For Infrainguinal Bypass Surgery: Are They Worth The Effort?”
2005 ANZSVS VASCULAR 2005, Sydney, NSW
“The Origins of Intimal Hyperplasia: Could it be the fibrocyte?”
2005 RACS ANNUAL SCIENTIFIC CONGRESS, Perth, WA
“The Origins of Intimal Hyperplasia: Could it be the fibrocyte?”
2004 RACS ANNUAL SCIENTIFIC CONGRESS, Melbourne, VIC
“Diverticulectomy is not adequate treatment for the short Meckel’s with heterotopic mucosa”
2003 NSW REGISTRARS PAPER DAY, Sydney, NSW
“Safe Diverticulectomy for the Meckel’s Diverticulum with Heterotopic Mucosa”
2016 FIREMAN VASCULAR CENTER VISITING PROFESSOR
